Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1216 AL 1230

[Analysis of cerebrospinal fluid in the diagnosis of cognitive impairment and dementia]

Frederiksen KS, Hasselbalch S, Waldemar G.

Ugeskr Laeger. 2020 Nov 2;182(45):V05200352.

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Funnell C, Feldman HH, Mackenzie IRA, DeMarco ML.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):357-359. doi: 10.1097/WAD.0000000000000372.

A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction

Spooner A, Chen E, Sowmya A, Sachdev P, Kochan NA, Trollor J, Brodaty H.

Sci Rep. 2020 Nov 23;10(1):20410. doi: 10.1038/s41598-020-77220-w.

Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis

Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T.

Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.

Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles

Llano DA, Issa LK, Devanarayan P, Devanarayan V, Alzheimer's Disease Neuroimaging Initiative Adni.

Cells. 2020 Nov 28;9(12):2556. doi: 10.3390/cells9122556.

The Role of Mitochondrial Calcium Homeostasis in Alzheimer's and Related Diseases

Ryan KC, Ashkavand Z, Norman KR.

Int J Mol Sci. 2020 Dec 1;21(23):9153. doi: 10.3390/ijms21239153.

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Breijyeh Z, Karaman R.

Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.

Inflammatory Biomarkers in AD: Implications for Diagnosis

Kim J, Kim YK.

Curr Alzheimer Res. 2020;17(11):962-971. doi: 10.2174/1567205017666201223152612.

A narrative review of brain-derived neurotrophic factor (BDNF) on cognitive performance in Alzheimer's disease

Ismail NA, Leong Abdullah MFI, Hami R, Ahmad Yusof H.

Growth Factors. 2020 Jun-Jul;38(3-4):210-225. doi: 10.1080/08977194.2020.1864347. Epub 2021 Jan 11.

Interacting influences of aging and Alzheimer's disease on circadian rhythms

Duncan MJ.

Eur J Neurosci. 2020 Jan;51(1):310-325. doi: 10.1111/ejn.14358. Epub 2019 Feb 21.

Reduction of recruitment costs in preclinical AD trials: validation of automatic pre-screening algorithm for brain amyloidosis

Ansart M, Epelbaum S, Gagliardi G, Colliot O, Dormont D, Dubois B, Hampel H, Durrleman S; Alzheimer’s Disease Neuroimaging Initiative* and the INSIGHT-preAD study.

Stat Methods Med Res. 2020 Jan;29(1):151-164. doi: 10.1177/0962280218823036. Epub 2019 Jan 30.

Microglial phagocytosis in aging and Alzheimer's disease

Gabandé-Rodríguez E, Keane L, Capasso M.

J Neurosci Res. 2020 Feb;98(2):284-298. doi: 10.1002/jnr.24419. Epub 2019 Apr 3.

Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system

Quitterer U, AbdAlla S.

Pharmacol Res. 2020 Apr;154:104230. doi: 10.1016/j.phrs.2019.04.014. Epub 2019 Apr 13.

Sensory-Based Interventions for Adults with Dementia and Alzheimer's Disease: A Scoping Review

Smith BC, D'Amico M.

Occup Ther Health Care. 2020 Jul;34(3):171-201. doi: 10.1080/07380577.2019.1608488. Epub 2019 May 8.

Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease

Kempuraj D, Ahmed ME, Selvakumar GP, Thangavel R, Dhaliwal AS, Dubova I, Mentor S, Premkumar K, Saeed D, Zahoor H, Raikwar SP, Zaheer S, Iyer SS, Zaheer A.

Neuroscientist. 2020 Apr;26(2):134-155. doi: 10.1177/1073858419848293. Epub 2019 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias